La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Neurogene Gestion
Gestion contrôle des critères 2/4
Neurogene's CEO is Rachel McMinn, appointed in Jan 2018, has a tenure of 6.58 years. total yearly compensation is $1.08M, comprised of 43.3% salary and 56.7% bonuses, including company stock and options. directly owns 9.62% of the company’s shares, worth $43.79M. The average tenure of the management team and the board of directors is 0.7 years and 0.7 years respectively.
Informations clés
Rachel McMinn
Directeur général
US$1.1m
Rémunération totale
| Pourcentage du salaire du PDG | 43.3% |
| Durée du mandat du directeur général | 6.6yrs |
| Propriété du PDG | 9.6% |
| Durée moyenne d'occupation des postes de direction | less than a year |
| Durée moyenne du mandat des membres du conseil d'administration | less than a year |
Mises à jour récentes de la gestion
Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$2m |
| Mar 31 2024 | n/a | n/a | US$9m |
| Dec 31 2023 | US$1m | US$468k | US$14m |
| Sep 30 2023 | n/a | n/a | -US$51m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$52m |
| Dec 31 2022 | US$657k | US$448k | -US$55m |
Rémunération vs marché: Rachel's total compensation ($USD1.08M) is below average for companies of similar size in the US market ($USD2.44M).
Rémunération et revenus: Rachel's compensation has been consistent with company performance over the past year.
PDG
Rachel McMinn (51 yo)
6.6yrs
Titularisation
US$1,080,629
Compensation
Dr. Rachel L. McMinn, Ph D., is the Founder of Neurogene Inc. and Chief Executive Officer and Executive Chair of Board since December 2023. Dr. McMinn founded Private Neurogene in January 2018 and served a...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Founder | 6.6yrs | US$1.08m | 9.62% $ 43.8m | |
| President | less than a year | US$1.13m | 0.41% $ 1.9m | |
| Chief Scientific Officer | less than a year | US$784.32k | 0.16% $ 714.1k | |
| Senior Vice President of Business Operations | no data | pas de données | pas de données | |
| Senior VP & General Counsel | less than a year | pas de données | 0% $ 0 | |
| Senior Vice President of Early Clinical & Translational Research | no data | pas de données | pas de données | |
| Senior Vice President of Regulatory Affairs | no data | pas de données | pas de données | |
| Senior Vice President of Technical Operations | no data | pas de données | pas de données | |
| Chief Medical Officer | less than a year | pas de données | pas de données |
0.7yrs
Durée moyenne de l'emploi
51yo
Âge moyen
Gestion expérimentée: NGNE's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Founder | less than a year | US$1.08m | 9.62% $ 43.8m | |
| Independent Director | less than a year | US$64.08k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$71.62k | 0% $ 0 | |
| Independent Director | 5yrs | US$62.12k | 0% $ 0 | |
| Independent Director | less than a year | pas de données | pas de données | |
| Independent Director | less than a year | pas de données | 0% $ 0 |
0.7yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Conseil d'administration expérimenté: NGNE's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.